Cohort Study of HIV-positive People, Treated With Long Acting Antiretroviral Therapy

NCT05663580 · clinicaltrials.gov ↗

RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Cabotegravir 600mg/3mL, Rilpivirine 900mg/3mL

Sponsor

Castagna Antonella